Mar 18, 2026 04:05PM

Jan 7, 2026 12:43AM

Sep 3, 2025 06:41AM

Sep 2, 2025 06:58AM

Jul 2, 2025 04:00PM

Jun 10, 2025 04:00PM

Jun 10, 2025 04:00PM Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors

Apr 24, 2025 04:01PM

Feb 26, 2025 04:00PM

May 20, 2024 06:30AM

Sep 26, 2023 05:05PM

Mar 31, 2023 06:23AM

Mar 29, 2023 04:00PM

Jan 4, 2023 04:01PM Inventiva (IVA) announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis

Jan 4, 2023 04:00PM

Dec 12, 2022 02:30AM

Nov 28, 2022 04:00PM

Nov 28, 2022 04:00PM

Nov 21, 2022 04:01PM

Nov 21, 2022 04:00PM

Nov 10, 2022 04:00PM Inventiva reports 2022 Third Quarter Financial Information¹

Oct 31, 2022 03:00AM

Oct 21, 2022 04:00PM

Sep 22, 2022 02:30AM

Sep 21, 2022 04:40PM

Mar 8, 2022 05:51AM

Mar 8, 2022 02:00AM

Mar 7, 2022 04:26PM Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and cedirogant in psoriasis

Mar 7, 2022 04:00PM

Mar 1, 2022 04:00PM

Feb 28, 2022 04:00PM

Feb 14, 2022 04:00PM

Jan 31, 2022 04:00PM

Jan 31, 2022 04:00PM

Jan 20, 2022 04:00PM Inventiva announces participation at several conferences in January and February 2022

Dec 16, 2021 04:00PM

Dec 6, 2021 04:00PM

Nov 10, 2021 04:00PM

Nov 3, 2021 04:00PM

Oct 27, 2021 04:00PM

Oct 20, 2021 05:07PM

Oct 18, 2021 04:00PM Inventiva announces the presentation of five scientific abstracts at the AASLD The Liver Meeting™ 2021

Sep 28, 2021 04:00PM

Sep 23, 2021 02:45AM

Sep 21, 2021 04:01PM

Sep 21, 2021 04:00PM

Sep 20, 2021 04:10PM

Sep 16, 2021 04:00PM

Sep 10, 2021 09:00AM Inventiva’s 2021 First-Half Financial Results Presentation

Sep 8, 2021 04:00PM

322,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All